Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis
Activation of PI3K plays a role in pulmonary inflammation. Here, the authors develop a drug inhibitor of PI3K, and show that it inhibits lung inflammation and damage in mouse models of asthma and lung fibrosis.
Guardado en:
Autores principales: | Carlo C. Campa, Rangel L. Silva, Jean P. Margaria, Tracey Pirali, Matheus S. Mattos, Lucas R. Kraemer, Diego C. Reis, Giorgio Grosa, Francesca Copperi, Eduardo M. Dalmarco, Roberto C. P. Lima-Júnior, Silvio Aprile, Valentina Sala, Federica Dal Bello, Douglas Silva Prado, Jose Carlos Alves-Filho, Claudio Medana, Geovanni D. Cassali, Gian Cesare Tron, Mauro M. Teixeira, Elisa Ciraolo, Remo C. Russo, Emilio Hirsch |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ffd766e4bb69453a8c45e742f2d6dd75 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Recent Advances in the Synthesis of Polyamine Derivatives and Their Applications
por: Artemiy Nichugovskiy, et al.
Publicado: (2021) -
MEPicides: potent antimalarial prodrugs targeting isoprenoid biosynthesis
por: Rachel L. Edwards, et al.
Publicado: (2017) -
pH-sensitive doxorubicin-tocopherol succinate prodrug encapsulated in docosahexaenoic acid-based nanostructured lipid carriers: An effective strategy to improve pharmacokinetics and reduce toxic effects
por: Eduardo Burgarelli Lages, et al.
Publicado: (2021) -
Structure-guided microbial targeting of antistaphylococcal prodrugs
por: Justin J Miller, et al.
Publicado: (2021) -
Correction: Structure-guided microbial targeting of antistaphylococcal prodrugs
por: Justin J Miller, et al.
Publicado: (2021)